Abrilada

Active Ingredient(s): Adalimumab-afzb
FDA Approved: * November 15, 2019
Pharm Company: * PFIZER INC
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Abrilada Overview

Adalimumab, sold under the brand name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[2][3][4] Use is generally only recommended in people who have not responded to other treatments.[3] It is used by injection under the skin.[2] ...

Read more Abrilada Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Adalimumab

Recent Abrilada Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Adalimumab-afzb or a similar ingredient: (11 results)

• ADALIMUMAB
• ADALIMUMAB-ADAZ
• ADALIMUMAB-ADBM
• ADALIMUMAB-AFZB
• ADALIMUMAB-ATTO
• ADALIMUMAB-BWWD
• AMJEVITA Adalimumab-atto
• CYLTEZO Adalimumab-adbm
• HADLIMA Adalimumab-bwwd
• HUMIRA Adalimumab66 discussions
• HYRIMOZ Adalimumab-adaz